Who
Michael Heltzen
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, eXoZymes.
In numbers
- Trades disclosed
- 17
- Buys
- 6
- Sells
- 0
- Bought
- $66K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Nov 2024
- Last trade
- 26 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $304 at $7.58 | filing |
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,845251 at $7.35 | filing |
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,900250 at $7.60 | filing |
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $304 at $7.58 | filing |
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,845251 at $7.35 | filing |
| 26 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,900250 at $7.60 | filing |
| 25 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,880250 at $7.52 | filing |
| 25 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $750100 at $7.50 | filing |
| 25 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,880250 at $7.52 | filing |
| 25 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $750100 at $7.50 | filing |
| 19 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $57K8,841 at $6.40 | filing |
| 19 Aug 2026filed 2 Sep 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $57K8,841 at $6.40 | filing |
| 2 Jul 2025filed 2 Jul 2025 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $11K1,040 at $10.22 | filing |
| 17 Jun 2025filed 20 Jun 2025 | EXOZ eXoZymesoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,817 at $0.00 | filing |
| 17 Jan 2025filed 21 Jan 2025 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $19K1,767 at $10.78 | filing |
| 16 Jan 2025filed 21 Jan 2025 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $1,297121 at $10.72 | filing |
| 15 Nov 2024filed 19 Nov 2024 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Bought | $22K1,984 at $11.10 | filing |
News
Financial Comparison: ImmunityBio (NASDAQ:IBRX) and eXoZymes (NASDAQ:EXOZ)EXOZ · dailypolitical.com · 21 Oct 2026Comparing eXoZymes (NASDAQ:EXOZ) and Allogene Therapeutics (NASDAQ:ALLO)EXOZ · dailypolitical.com · 16 Oct 2026
0 headlines in the last 90 days name Michael Heltzen; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.